NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
5.75
-0.28 (-4.64%)
Nov 12, 2026, 4:00 PM EST - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $72.21 million as of November 12, 2026. It is the 26,973rd most valuable company in the world and the 4,283rd biggest in the United States. Its market cap has increased by 181.25% in one year.
Market Cap
72.21M
Enterprise Value
68.16M
1-Year Change
181.25%
Global Rank
Country Rank
#4,283 United States
Category
ChartMarket Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $72.21M, an increase of 293.03%. That is a compound annual growth rate of 52.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 72.21M | 49.30% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 82.31M |
| Corbus Pharmaceuticals Holdings | 80.57M |
| Tiziana Life Sciences | 79.63M |
| Rani Therapeutics Holdings | 78.97M |
| Coya Therapeutics | 75.77M |
| Tonix Pharmaceuticals Holding | 75.59M |
| OKYO Pharma | 74.00M |
| PDS Biotechnology | 72.47M |